Literature DB >> 14739229

The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis.

Kirstin Veugelers1, Bruce Motyka, Christine Frantz, Irene Shostak, Tracy Sawchuk, R Chris Bleackley.   

Abstract

Cytotoxic T lymphocytes and natural killer cells destroy target cells via the directed exocytosis of lytic effector molecules such as perforin and granzymes. The mechanism by which these proteins enter targets is uncertain. There is ongoing debate over whether the most important endocytic mechanism is nonspecific or is dependent on the cation-independent mannose 6-phosphate receptor. This study tested whether granzyme B endocytosis is facilitated by dynamin, a key factor in many endocytic pathways. Uptake of and killing by the purified granzyme B molecule occurred by both dynamin-dependent and -independent mechanisms. However most importantly, serglycin-bound granzyme B in high-molecular-weight degranulate material from cytotoxic T lymphocytes predominantly followed a dynamin-dependent pathway to kill target cells. Similarly, killing by live cytotoxic T lymphocytes was attenuated by a defect in the dynamin endocytic pathway, and in particular, the pathways characteristically activated by granzyme B were affected. We therefore propose a model where degranulated serglycin-bound granzymes require dynamin for uptake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739229     DOI: 10.1182/blood-2003-06-2156

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients.

Authors:  Lu He; Xinke Zhou; Chen Qu; Yunqiang Tang; Qiong Zhang; Jian Hong
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

3.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

4.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

Review 5.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 6.  In life there is death: How epithelial tissue barriers are preserved despite the challenge of apoptosis.

Authors:  Kinga Duszyc; Guillermo A Gomez; Kate Schroder; Matthew J Sweet; Alpha S Yap
Journal:  Tissue Barriers       Date:  2017-07-07

7.  Cell binding, internalization and cytotoxic activity of human granzyme B expressed in the yeast Pichia pastoris.

Authors:  Ulrike Giesübel; Benjamin Dälken; Hayat Mahmud; Winfried S Wels
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

8.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity.

Authors:  Laura N Arneson; Colin M Segovis; Timothy S Gomez; Renee A Schoon; Christopher J Dick; Zhenkun Lou; Daniel D Billadeau; Paul J Leibson
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Mast cell-derived particles deliver peripheral signals to remote lymph nodes.

Authors:  Christian A Kunder; Ashley L St John; Guojie Li; Kam W Leong; Brent Berwin; Herman F Staats; Soman N Abraham
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.